Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS
NCT00002181 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
The purpose of this study is to see if cidofovir gel (Forvade) is safe and effective in treating herpes simplex in patients with AIDS who do not respond to acyclovir.
Conditions
- Herpes Simplex
- HIV Infections
Interventions
- DRUG
-
Cidofovir
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?
NCT00860977 ·Status: COMPLETED ·Phase: PHASE3
-
SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir
NCT00002310 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2
NCT01047540 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood
NCT00001115 ·Status: COMPLETED ·Phase: NA
-
Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis in Immunocompromised Patients
NCT00735761 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir
NCT00000985 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes
NCT00076232 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
NCT00005663 ·Status: UNKNOWN ·Phase: PHASE3
-
A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621
NCT03595995 ·Status: UNKNOWN ·Phase: PHASE2
-
Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix
NCT00946556 ·Status: COMPLETED ·Phase: NA
-
Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
NCT01915212 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons
NCT00079911 ·Status: TERMINATED ·Phase: PHASE4
-
The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients
NCT00002404 ·Status: COMPLETED ·Phase: NA
-
Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents
NCT00375570 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)
NCT00371592 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
NCT00002084 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes
NCT01154543 ·Status: COMPLETED
-
A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease
NCT05500053 ·Status: COMPLETED
-
A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3
NCT00000712 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis
NCT00878072 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies
NCT00002021 ·Status: COMPLETED ·Phase: NA
-
Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster
NCT00006131 ·Status: COMPLETED ·Phase: NA
-
A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes
NCT05298254 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir
NCT00219310 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons
NCT01059084 ·Status: WITHDRAWN ·Phase: NA